Attenuation of Japanese encephalitis virus by selection of its mouse brain membrane receptor preparation escape variants

Virology

Volumn 241, Issue 1, 1998, Pages 30-36

  Ni, Haolin ^a   Barrett, Alan D T ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Attenuation; Japanese encephalitis; Membrane receptor

Indexed keywords

VIRUS RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; EPIDEMIC ENCEPHALITIS; FEMALE; IMMUNOGENICITY; JAPANESE ENCEPHALITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VERO CELL; VIRUS ATTENUATION; VIRUS INFECTIVITY;

ANIMALIA; DNA VIRUSES; JAPANESE ENCEPHALITIS VIRUS; RNA VIRUSES;

EID: 0032005706     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8956     Document Type: Article

References (30)

1. Anderson R., King A. D., Innis B. L. Correlation of E protein binding with cell suceptibility to dengue 4 virus infection. J. Gen. Virol. 73:1992;2155-2159.
2. Cao J. X., Ni H., Sil B. K., Ryman K. D., Barrett A. D. T. Passage of Japanese encephalitis virus in HeLa cells results in mutations in the structural protein genes and attenuation of virulence in mice. J. Gen. Virol. 76:1995;2757-2764.
3. Cecilia D., Gould E. A. Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutants. Virology. 181:1991;70-77.
4. Chase A. Magic Shot: A Human and Scientific Account of Long and Continuing Struggle to Eradicate Infectious Diseases by Vaccination. 1982;Morrow, New York. p. 1.
5. Chen Y., Maguire T., Hileman R. E., Fromm J. R., Esko J. D., Linhardt R. J., Marks R. M. Dengue virus infectivity depends on envelope protein binding to target cell heparin sulfate. Nature Med. 3:1997;866-871.
6. Devereux J., Haeberli P., Smithies O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12:1984;387-395.
7. Fields B. N., Greene M. I. Genetic and molecular mechanisms of viral pathogenesis: Implications for prevention and treatment. Nature. 300:1982;19-23.
8. Gao G. F., Hussain M. H., Reid H. W., Gould E. A. Identification of naturally occurring monoclonal antibody escape variants of louping ill virus. J. Gen. Virol. 75:1994;609-614.
9. Guirakhoo F., Heinz F. X., Mandl C. W., Holzmann H., Kunz C. Fusion activity of flaviviruses: comparison of mature and immature (prM-containing) tick-borne encephalitis virions. J. Gen. Virol. 72:1991;1323-1329.
10. Hasegawa H., Yoshida M., Shiosaka T., Fujita S., Kobayashi Y. Mutation in the envelope protein of Japanese encephalitis virus affect entry into cultured cells and virulence in mice. Virology. 191:1992;158-165.
11. Heinz F. X., Auer G., Stiasny K., Holzmann H., Mandl C., Guirakhoo F., Kunz C. The interactions of the flavivirus envelope proteins: implications for virus entry and release. Arch. Virol. 9:1994;339-348.
12. Hiramatsu K., Tadano M., Men R., Lai C. J. Mutation analysis of a neutralization epitope on the dengue type 2 virus envelope protein: Monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence. Virology. 224:1996;437-445.
13. Holzmann H., Mandl C. W., Guirakhoo F., Heinz F. X., Kunz C. Characterization of antigenic variants of tick-borne encephalitis virus selected with neutralizing monoclonal antibodies. J. Gen. Virol. 70:1989;219-222.
14. Huang C.H. Studies of Japanese encephalitis in China. Adv. Virol. Res. 27:1982;71-101.
15. Jiang W. R., Lowe A., Higgs S., Reid H., Gould E. A. Single amino acid codon changes detected in louping ill virus antibody-resistance mutatants with reduced neurovirulence. J. Gen. Virol. 74:1993;931-935.
16. Lentz T. L. The recognition event between virus and host cell receptor: A target for antiviral agents. J. Gen. Virol. 71:1990;751-766.
17. Marianneau P., Megret F., Oliver R., Morens D. M., Deubel V. Dengue 1 virus binding to the human hepatoma HepG2 and simian Vero cell surfaces differs. J. Gen. Virol. 77:1996;2547-2554.
18. 1. Eur. J. Pharmacol. 90:1983;151-153.
19. Mims C. A. Virus receptors and cells tropism. J. Infect. 12:1986;199-203.
20. Monath T. P. Flaviviruses. Virology. 1990;Raven Press, New York. p. 763-814.
21. Ni H., Barrett A. D. T. Analysis of molecular basis of high neuro-invasiveness for mice of wild-type JE virus strain P3. J. Gen. Virol. 77:1996;1449-1455.
22. Ni H., Burns N. J., Chang G. J., Zhang M. J., Wills M. R., Trent D. W., Sanders P. G., Barrett A. D. T. Comparison of nucleotide and deduced amino acid sequence of the 5′ non-coding region and structural protein genes of the wild-type Japanese encephalitis virus strain SA14 and its attenuated vaccine derivatives. J. Gen. Virol. 75:1994;505-1510.
23. Norkin L. C. Virus receptors: Implications for pathogenesis and the antiviral agents. Clin. Microbiol. Rev. 8:1995;293-315.
24. Paulson J. C. Interaction of animal viruses with cell surface receptors. Conn P. M. The Receptors. 1985;131-219 Academic Press, Orlando.
25. Queen C. G., Korn L. J. A comprehensive sequence analysis program for the IBM personal computer. Nucleic Acids Res. 12:1984;581-599.
26. Rey F. A., Heinz F. X., Mandl C., Kunz C., Harrison S. C. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature. 375:1995;291-298.
27. Sanchez I. J., Ruiz B. H. A single nucleotide change in the E protein of dengue 2 Mexican strain affects neurovirulence in mice. J. Gen. Virol. 77:1996;2541-2545.
28. Westaway E. G., Brinton M. A., Gaidamovich S. Y., Horzinek M. C., Igarashi A., Kaarianen L., Lvov D. K., Porterfield J. S., Fussell P. K., Trent D. W. Flaviviridae. Intervirology. 24:1985;183-192.
29. Wills M. R., Sil B. K., Cao J. X., Barrett A. D. T. Antigenic characterization of the live attenuated Japanese encephalitis vaccine virus SA14-14-2: A comparison with isolates of virus covering a wild geographic area. Vaccine. 10:1992;861-872.
30. History of International Public Health. 1980;WHO, Geneva.